Deniz YALMAN, Fatma SERT, Recep SAVAŞ, Aylin ORAL, Serdar ÖZKÖK

Prognostic Value of FDG-PET/CT Parameters in Patients with Locally Advanced Rectal Cancer Treated with Neoadjuvant Approach

OBJECTIVETo determine the prognostic and/or predictive role of 18F-FDG PET/CT parameters, such as SUVmax, SUVmean, Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG=MTVxSUVmean), for the patients with locally advanced rectal cancer (LARC) treated with neoadjuvant radiotherapy±chemotherapy.METHODSBetween January 2005 and December 2016, a total of 106 patients with clinical T3-4 and/or N+ rectal cancer without distant metastasis were included in this study. Correlation between metabolic and volumetric parameters and tumor characteristics was evaluated. Prognostic factors for overall sur-vival (OS), local recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS) were analyzed.RESULTSThe median follow-up duration for all patients was 39.0 months (range, 6–103 months). Pathologic complete response (pCR) was defined as the absence of viable cancer cells in the resected specimen (ypT0N0). pCR was achieved in 17% of all cases (18/106). There was a weak correlation between SUV-max of primary tumor and MTV ([r]=0.238; p

PDF

___

1. van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, et al. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer 2013;49(13):2784–90.
2. Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, et al. Multidisciplinary rectal cancer management: 2nd European rectal cancer consensus conference (EURECA-CC2). Radiother Oncol 2009;92(2):148–63.
3. Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 2012;13(7):679–87.
4. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 2012;30(16):1926–33.
5. Onaitis MW, Noone RB, Hartwig M, Hurwitz H, Morse M, Jowell P, et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 2001;233(6):77885.
6. Kaminsky-Forrett MC, Conroy T, Luporsi E, Peiffert D, Lapeyre M, Boissel P, et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer. Int J Radiat Oncol Biol Phys 1998;42(5):935–41.
7. Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009;74(3):673–88.
8. Brown G, Davies S, Williams GT, Bourne MW, Newcombe RG, Radcliffe AG, et al. Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer 2004;91(1):23–9.
9. Joye I, Deroose CM, Vandecaveye V, Haustermans K. T he role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review. Radiother Oncol 2014;113(2):158–65.
10. Kim SH, Song BI, Kim BW, Kim HW, Won KS, Bae SU, et al. Predictive Value of [18F]FDG PET/CT for Lymph Node Metastasis in Rectal Cancer. Sci Rep 2019;9(1):4979.
11. van Stiphout RG, Valentini V, Buijsen J, Lammering G, Meldolesi E, van Soest J, et al. Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: a multicentric prospective study with external validation. Radiother Oncol 2014;113(2):215–22.
12. Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-le Rest C. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging 2011;38(7):1191–202.
13. Hyun SH, Choi JY, Shim YM, Kim K, Lee SJ, Cho YS, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol 2010;17(1):115–22.
14. Zhang C, Chen Y, Xue H, Zheng P, Tong J, Liu J, et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 2009;124(1):167–73.
15. National Comprehensive Cancer Network. Available at: https://www.nccn.org/professionals/physician_gls/ pdf/rectal.pdf assessed at 06/05/2019. Accessed Feb 4, 2020.
16. Bang JI, Ha S, Kang SB, Lee KW, Lee HS, Kim JS, et al. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer. Eur J Nucl Med Mol Imaging 2016;43(3):422–31.
17. Kim SJ, Chang S. Volumetric parameters changes of sequential 18F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clin Nucl Med 2015;40(12):930–5.
18. Everaert H, Hoorens A, Vanhove C, Sermeus A, Ceulemans G, Engels B, et al. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDGPET. Int J Radiat Oncol Biol Phys 2011;80(1):91–6.
19. Herrmann K, Bundschuh RA, Rosenberg R, Schmidt S, Praus C, Souvatzoglou M, et al. Comparison of different SUVbased methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI. Mol Imaging Biol 2011;13(5):1011–9.
20. Hur H, Kim NK, Yun M, Min BS, Lee KY, Keum KC, et al. 18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer. J Surg Oncol 2011;103(1):17–24.
21. Kim JW, Kim HC, Park JW, Park SC, Sohn DK, Choi HS, et al. Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy. Int J Colorectal Dis 2013;28(9):1217–24.
22. Sun W, Xu J, Hu W, Zhang Z, Shen W. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer. Colorectal Dis 2013;15(5):e231–8.
23. Hatt M, van Stiphout R, le Pogam A, et al. Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET. Acta Oncol. 2013;52:619–626.
24. Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, et al. Comparison of 18FFDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer. Abdom Imaging 2015;40(5):1190–202.
25. Huang W, Fan M, Liu B, Fu Z, Zhou T, Zhang Z, et al. Value of metabolic tumor volume on repeated 18F-FDG PET/CT for early prediction of survival in locally advanced non–small cell lung cancer treated with concurrent chemoradiotherapy. J Nucl Med 2014;55(10):1584–90.
26. Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, et al. Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer. Dis Colon Rectum 2018;61(3):320–7.
27. Chung MK, Jeong HS, Park SG, Jang JY, Son YI, Choi JY, et al. Metabolic tumor volume of [18F]-flu orodeoxyglucose positron emission tomography/ computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res 2009;15(18):5861–8.
28. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2(3):159–71.
29. Jo HJ, Kim SJ, Lee HY, Kim IJ. Prediction of survival and cancer recurrence using metabolic volumetric parameters measured by 18F-FDG PET/CT in patients with surgically resected rectal cancer. Clin Nucl Med 2014;39(6):493–7.
30. Ogawa S, Itabashi M, Kondo C, Momose M, Sakai S, Kameoka S. Prognostic Value of Total Lesion Glycolysis Measured by 18F-FDG-PET/CT in Patients with Colorectal Cancer. Anticancer Res 2015;35(6):3495500.